Associate Professor

Research Interest

  1. PI3K-AKT signalling pathway as a target for therapeutic intervention in Acute Lymphoblastic Leukemia.
  2. Isolation, characterization and identification of anti cancer compounds from Indian medicinal plants.
  3. Value addition of Curcumin and its testing as an anti leukemic therapy
  4. Mapping normal and cancer cell signalling networks: towards single cell proteomics.

Teaching

  1. Botany (Under Graduate – Gurudas College)- since 2001
  2. Founder Head: Department of Microbiology, Gurudas College (2002-2004)
  3. Former Guest Faculty (Post Graduate – Dept. Of Biotechnology; Presidency University)
  4. Former Guest Faculty (Post Graduate – Dept. Of Genetics; University of Calcutta)
  5. Guest Faculty (Post Graduate Department of Microbiology; Bidhannagar Govt. College)

Professional Membership

  1. Associate Member of “American Society of Hematology”, USA
  2. Life member of “Indian Society of Cell Biology”; INDIA
  3. Life member of “Indian Science Congress Association: (I.S.C.A.)
  4. Life member of “Society for Biological Chemists-India” (S.B.C.I.)
  5. Life member of “The Cytometry Society” INDIA.

Important Publications

  1. Priya K Gopal. Mausumi Paul and Santanu Paul. Curcumin induces caspase mediated apoptosis in JURKAT cells by disrupting the redox balance. Asian Pacific Journal of Cancer Prevention. 2014 :15(1):93-100.
  2. Priya K Gopal, Mausumi Paul and Santanu Paul. Anti leukemic potential of different Fenugreek seed germplasms. Am Jr Soc Issu Humn. 2014: 45-49.
  3. Tathagata Deb. Priya K Gopal, Durba Ganguly, Piyal Das, Manju Bikash Saha, Santanu Paul and Saurabh Das. Enhancement of anti-leukemic potential of 2-hydroxyphenyl azo-2-napthanol (HPAN) on MOLT-4 cells through conjugation with Cu(II). Royal Society of Chemistry Advances. 2014. (Accepted).
  4. Damle RN, Temburni S, Banapour T, Paul S, Mongini PK, Allen SL, Kolitz JE, Rai KR, Chiorazzi N. T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients. Blood. 2012:120(12): 2438-2449.
  5. Acharya S. N., Acharya, K., Paul, S. and Basu S. K. Antioxidant and antileukemic properties of selected fenugreek (Trigonella foenum-graecum L.) genotypes grown in Western Canada. Canadian Journal of Plant Science. 2011: 91: 99-105
  6. Piyal Das, Partha Sarathi Guin, Parikshit C. Mandal, Mausumi Paul, Santanu Paul and Saurabh Das. Cyclic voltammetric studies of 1,2,4-trihydroxy-9,10-anthraquinone, its interaction with calf thymus DNA and anti-leukemic activity on MOLT-4 cell lines: A comparison with anthracycline anticancer drugs. Journal of Physical Organic Chemistry. 2010, 23:1–12
  7. Ratna Chatterjee, Omkar Singh, Lalawmpuii Pachuau, Shiba Prasad Malik, Mausumi Paul, Kakali Bhadra, Santanu Paul, Gopinatha Suresh Kumar, Nirup Bikash Mondal and Sukdeb Banerjee. Identification of a sulfoquinovosyldiacylglyceride from Azadirachta indica and studies on its cytotoxic activity and DNA binding properties. Bioorganic and Medicinal Chemistry Letters. 2010; 20(22):6699-6702
  8. McCarthy BA, Reddi AS, Coakley KM, Nguyen SM, Nayal RR, Javdan M, Paul S, Ende N. Administration of Human Umbilical Cord Blood Cells Produces Interleukin-10 (IL-10) in IL-10 Deficient Mice without Immunosuppression. Curr Stem Cell Res Ther. 2010; 5(1):13-17
  9. Till Seiler, Manuela Woelfle, Sophia Yancopoulos, Rosa Catera, Wentian Li, Katerina Hatzi, Carol Moreno, Marcela Torres, Santanu Paul, Hartmut Dohner, Stephan Stilgenbauer, Matthew S. Kaufman, Jonathan E. Kolitz, Steven L Allen, Kanti R Rai, Charles C Chu, and Nicholas Chiorazzi. Characterization of structurally-defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells. Blood. 2009; 22;114(17):3508-9.
  10. McCarthy B, Boyle E, Wang XP, Guzowski D, Paul S, Catera R, Trott J, Yan X, Croce CM, Damle R, Yancopoulos S, Messmer BT, Lesser M, Allen SL, Rai KR, and Chiorazzi N. Surface Expression of Bcl2 in Chronic Lymphocytic Leukemia and Other B-cell Leukemias and Lymphomas without a Breakpoint t(14:18). Molecular Medicine. 2008; 14(9-10):618-27.)
  11. Ghosh S, Bandyopadhyay S, Mukherjee K, Mallick A, Pal S, Mandal C, Bhattacharya DK, Mandal C. O-acetylation of sialic acids is required for the survival of lymphoblasts in childhood acute lymphoblastic leukemia (ALL). Glycoconj J. 2007; 24(1):17-24.
  12. Ghosh S, Bandyopadhyay S, Pal S, Sinha D, Mallick A, Chatterjee M, Mandal C and Mandal C. 9-O-acetylated sialoglycoproteins: novel molecules in childhood acute lymphoblastic leukaemia (ALL). National Academy Science Letters. 2006; 29: 17-24.
  13. Paul M, Basu S and Paul S. Antibacterial activities of ginger (Zingiber officinaler Rosc) and turmeric (Curcuma domestica Loir.) Ind Jr of Bot Res. 2006; 2(2): 103-110.
  14. Bandyopadhyay S, Chatterjee M, Banavali SD, Pal S, Nair CN, Advani SH, Mandal C. Antibodies against 9-O-acetylated sialic acids in childhood acute lymphoblastic leukemia: a two-year study with 186 samples following protocol MCP 943. Indian J Biochem Biophys. 2006 Feb; 3(1):7-14.
  15. Ghosh S, Bandyopadhyay S, Mallick A, Pal S, Vlasak R, Bhattacharya DK, Mandal C. Interferon gamma promotes survival of lymphoblasts overexpressing 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia (ALL). J Cell Biochem. 2005; 95:206-16.
  16. Ghosh S, Bandyopadhyay S, Pal S, Das B, Bhattacharya DK, Mandal C. Increased interferon gamma production by peripheral blood mononuclear cells in response to stimulation of overexpressed disease-specific 9-O-acetylated sialoglycoconjugates in children suffering from acute lymphoblastic leukaemia. Br J Hematol 2005;128: 35-41.
  17. Pal S, Ghosh S, CN Mandal, Brossmer R,. Merling A, Schwartz-Albiez R, Bhattacharya DK, Mandal C. Purification and characterization of two novel 9-O-acetylated sialoglycoconjugates for monitoring the disease status in childhood acute lymphoblastic leukemia. Glycobiology 2004; 111:270-277.
  18. Pal S, Ghosh S, Bandyopadhyay S, Mandal CN, Bandhyopadhyay S, Bhattacharya D K, Mandal C. Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: a potential tool for long-term monitoring of children with acute lymphoblastic leukaemia. Inter J Cancer 2004; 11:270-277.
  19. Bandyopadhyay S, Chatterjee M, Pal S, Waller RF, Sundar S, McConville M, Mandal C. Purification, characterization of O-acetylated sialoglycoconjugate specific IgM and development of an enzyme linked immunosorbent assay for diagnosis and follow up of Indian Visceral Leishmaniasis patients. Diagn Microbiol Infect Dis 2004; 50:15-24.
  20. Pal S, Bandyopadhyay S, Chatterjee M, Bhattacherya DK, Minto L, Hal AG, Mandal C. Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukaemia. Clin Biochem 2004; 37:395-403.
  21. Chatterjee M, Chava AK, Kohla G, Pal S, Merling A, Hinderlich S, Unger U, Strasser P, Gerwig GJ, Kamerling JP, Vlasak R, Crocker PR, Schauer R, Schwartz- Albiez R, Mandal C. Identification and characterization of adsorbed serum sialoglycans on leishmania donovani promastigotes. Glycobiology 2003; 13:351-361.
  22. Pal S, Chatterjee M, DK Bhattacharya, S Bandhyopadhyay, C Mandal, C Mandal. O-acetyl sialic acid specific IgM in childhood acute lymphoblastic leukaemia. Glycoconjugate J, (2001) 18:529-537.
  23. Mandal C, Chatterjee M, Biswas C, Pal S, Sinha D, Sharma V, Pramanik T, Mallick A. Potential applications of Glycoconjugates in Medicine of the 21st Century. India Biotechnol Ass News Lett 2001; Jan-Feb: 37-39.
  24. Pal S, Sinha D, Chatterjee M, Bhattacharya DK, Mandal C. 9-O-acetylated sialoglycoconjugates as biomarkers on lymphoblasts of childhood Acute Lymphoblastic Leukemia. Leucocyte Typing VII Proc 7th HLDA meeting, Oxford University Press 2001; 60-62.
  25. Pal S, Chatterjee M, Bhattacharyya DK, Bandhyopadhyay S, Mandal C. Identification and purification of cytolytic antibodies directed against O-acetylate sialic acid in childhood acute lymphoblastic leukemia. Glycobiology 2000; 10:539-549.

Patents

  1. Mandal C, Pal S, Chatterjee M. Process for preparation of a biomarker specific for O-acetylated sialic acid useful for diagnosing, monitoring treatment outcome, and predicting relapse of lymphoblastic leukemia. 2004; US Patent No: 6693177 (Granted: 17/2/2004)
  2. Mandal C, Pal S, Chatterjee M, Bhattacharya DK. Process for the preparation of O-acetylated sialic acid specific immunoglobulin and method of quantification there of. 2000: European Patent no: 1083181 (filed on 01.19.2000 and Granted: 03/14/2001).
  3. Mandal C, Pal S, Chatterjee M, Bhattacharya DK. A process for the preparation of a novel biomarker specific for O-acetylated sialic acid useful for the diagnosis, monitoring outcome of treatment and prediction of relapse and biomarker prepared thereby; Indian Patent n: IN191209 [ Priority No: 1999DE000001192 filed on 8. 9.1999and Granted: 04/10/2003]

Book Chapters

  1. Gopal P and Paul S. Sustainable environmental technologies of the 21st Century. 2011:20-22. Green Technology and Environment: Efforts For Building A Sustainable Planet. The Science Association of Bengal, 2011.
  2. Acharya, S. N., Basu, S. K. Acharya, K, Paul, S., Datta Banik, S. and Prasad, R. 2011. Fenugreek: A spice, forage and nutraceutical crop. In: De. A. K. (edited) Spices: The elixir of life. Chapter 7. pp. 115-136.
  3. Paul S, McCarthy B and Paul M. Medicinal application of green tea and its polyphenolic catechins. Advances in medicinal plant research. Chapter 11, 2007:237-256 (Research Sign Post Publishing Company; New Delhi)
  4. Paul M and Paul S. Bioplastics from microbes: A new approach towards sustainable environment. Man and Environment. Chapter 14, 2007:229-236 (APH Publishing Corporations; New Delhi).

Ongoing Research Projects

  1. Title:Study of the anti-leukemic and anti-oxidant potential of some wild edible mushrooms of West Bengal: leading to chemical identification of the lead molecules.
    PI: Santanu Paul
    Agency: DBT (Govt. of WB)
    Period: 2014-2017
    Amount: Rs.35,95,200
  2. Title:Screening for  anti-leukemic activity of some wild edible mushrooms of India and unraveling the molecular mechanism involved in apoptosis.
    PI: Santanu Paul
    Agency: UGC; New Delhi
    Period: 2013-2016
    Amount: 14,85,800
  3. Title: Evaluation of plant crude extracts as potential anti-leukemic agent leading to chemical identification of the lead molecule and unraveling the molecular mechanism involved in apoptosis
    PI: Santanu Paul
    Agency: DST (WB)
    Period: 2011-2014
    Amount: Rs.19,59,100

Completed Research Projects

  1. Title: Telomere Reconstitution in Chronic Lymphocytic Leukemia
    PI: Santanu Paul
    Agency: Lauri Strauss Leukemia Foundation (USA)
    Period: 2005
    Amount: 20,000 USD
  2. Title: evaluation of novel curcumin analogues as anti-leukemic agents and elucidating its molecular mechanism leading to apoptosis
    PI: Santanu Paul
    Agency: University Grants Commission
    Period: 2008-2011
    Amount: Rs. 11,86,800

Research Group

    At present there are two research fellows at my “Laboratory of Experimental Immunology”. The laboratory started its journey from 2008.

  1. Priya Gopal (M.S in Microbiology from University of Calcutta): Ms Gopal is currently a Senior Research Fellow. She is screening different analogues of curcumin which has enhanced bioavailability than the mother Curcumin for its efficacy as an anti leukemic agent. Taking the most potent analogue she is trying to find out the molecular mechanism leading to apoptosis. She is also trying to identify the molecular targets of the most potent curcumin analogue in Acute Lymphoblastic Leukemia (ALL). The overall aim is value addition of Curcumin to find a novel drug for ALL.
  2. Swadesh Sarkar (M.S in Botany from University of Calcutta): Mr Sarkar is a Junior Research Fellow working at a DST (Govt. Of West Bengal) funded Research Project in my laboratory. He is at present isolating and characterizing structure of bio-molecules from selected Indian medicinal plants. He is testing the purified compounds for its anti leukemic effect and trying to know the molecular targets down regulated by the potent compound. His work, aims at identifying compound with potent anti leukemic activity from Indigenous plants.

Paper presented/Lectures Delivered

      1.Santanu Paul.Oxidative stress induced by novel curcumin analogue promotes apoptosis of leukemic cells by disrupting the PI3K/Akt signaling pathway.National Symposium on “Live organisms and their expression in the Environment. Organised by “Ethological Society of India and Department of Botany, University of Calcutta”.Nov 26-28, 2012. (Oral Presentation)

2.Santanu Paul. Panel development for multicolor Flow cytometry. 5th Annual meeting of the Cytometry Society, India and 13th INDO-US Cytometry Workshop on Application of Flow Cytometry; Kolkata, India. 12th-17th, October, 2012. (Invited Faculty)

3.Santanu Paul. Application of Flow Cytometry in Plant Sciences. 13th INDO-US CytometryWorkshop Application of Flow Cytometry in Nanotechnology and PlantGenomics.; Department of Biotechnology; IIT Guwahati, India. 8th – 10th October, 2012. (Invited Lecture)

4.Santanu Paul. Molecular mechanism of curcumin analogue-induced apoptosis in leukemia: involvement of PI3/AkT pathway. 1st International meet on Cell Signaling & Network (CeSiN). 11th – 13th September,2012;IICB;Kolkata.(Invited Lecture).

5.PriyaGopal, Mausumi Paul, Yousef Al-Abed and Santanu Paul. Novel curcumin analogues induces apoptosis in Acute Lymphoblastic Leukemia (ALL) by down-regulating Mcl-1 and up-regulating BimEL. 1st International meet on Cell Signaling & Network (CeSiN). 11th – 13th September,2012;IICB;Kolkata.(Poster presentation)

6. AveekDutta and Santanu Paul. Anti cancer Drugs from plant origin. 18th West Bengal Science and Technology Congress. 28th Feb-1st March, 2011; Narendrapur; Kolkata..(Poster presentation)

7. BijoyaDutta, PriyaGopal and Santanu Paul. Anti cancer Drugs from plant origin. 18th West Bengal Science and Technology Congress. 28th Feb-1st March, 2011; Narendrapur; Kolkata..(Poster presentation)

8. Isolation and Characterization of a sulfonoglycolipid from Azadirachtaindica: studies on its cytotoxic activity and DNA binding properties.18th West Bengal Science and Technology Congress. 28th Feb-1st March, 2011; Narendrapur; Kolkata..(Poster presentation)

9.Santanu Paul, Priya Gopal, Mausumi Paul and Nirup Bikash Mondal. Novel curcumin analogues induces apoptosis in Acute Lymphoblastic Leukemia (ALL) by down regulating Mcl-1 and up-regulating BimEL. XXXIV All India Cell Biology Conference and Symposium on “Quantitative Biology: from Molecules to Cells” Dec 4-6, 2010, Bose Institute, Kolkata, INDIA.

10.Santanu Paul, Priya Gopal, Mausumi Paul and Nirup Bikash Mondal. Novel curcumin analogue as potent anti leukemic agent. State Level UGC sponsored Seminar; Playing God: Expanding frontiers of Biotechnology. 6-7th Nov, 2009, Gurudas College, Kolkata, INDIA.

11.Acharya, S. N., Basu, S. K., Acharya, K., Paul, S., and Datta Banik, S 2009. International collaboration on identifying and enhancing the functional food and nutraceutical properties of an annual forage legume fenugreek (Trigonella foenum-graecum L.)14th World Congress on Clinical Nutrition and 5th International Congress on Cardiovascular Diseases, June 4-7, 2009, Kosice, Slovakia.

12.Rajendra N. Damle, Sonal Temburni, Tara Schaaf, Santanu Paul, Patricia Mongini, Steven L. Allen, Matthew Kaufman, Kanti R. Rai and Nicholas Chiorazzi. Efficiency of BCR: anti-BCR interaction dictates cellular outcomes of signaling in chronic lymphocytic leukemia cells. American Society for Hematology Conference; California, December 4-6, 2008; USA.

13.Rasmi AbuHelu, Santanu Paul, PatriciaMongini, Bettie Steinberg, Kanti R. Rai, Nicholas Chiorazzi. Signal Transduction in Chronic The 5th Palestinian Conference in Laboratory Medicine ‘Applications of Molecular Diagnostic Techniques in Clinical Laboratories’ March 28-29th, 2008; Palestine.

14.Santanu Paul, Rasmi AbuHelu, Pat Mongini, Christein Metz, Charles C Chu, Kanti Rai and Nicholas Chiorazzi. Low affinity interaction with CLL B-cell receptors induces apoptosis by down-regulating Mcl-1 and up-regulating BimEL. American Society for Hematology Conference; Atlanta, Georgia, December 8-10, 2007; USA.

15.Santanu Paul, Kanti Rai and Nicholas Chiorazzi. Activation of nucleic acid-sensing Toll-like receptors induces proliferation, cytokine production, immunogenic phenotype, and plasma cell differentiation of CLL cells and immunoglobulin production. American Society for Hematology Conference; Atlanta, Georgia, December 8-10, 2007; USA.

16.B. A. McCarthy, Tipping, M.E., Wang, X.P., Bennett, F., Li, W., Lesser, M., Paul, S., Boyle E., Moreno, C., Messmer, B., Gregersen, PK. , Rawstron A.C., Rai, K., and Chiorazzi, N. Expression Levels of a Single Gene, Lymphoid enhancer binding factor 1, Discriminates CLL B-Cells from Other B-Cell Malignancies. American Society for Hematology Conference; December 2007, Atlanta, Georgia, December 8-10, 2007; USA.

17.Santanu Paul, Rasmi AbuHelu, Pat Mongini, Christein Metz, Charles C Chu, Kanti Rai and Nicholas Chiorazzi. Low affinity anti-IgM antibody induce apoptosis in CLL B cells by downregulating MCL-1 and upregulating Bim. The XII International Workshop On CLL; September 14-16, 2007; London, UK.

18.Santanu Paul, Kanti Rai and Nicholas Chiorazzi. Activation of nucleic acid sensing toll like receptors induces proliferation, cytokine production, immunogenic phenotype and license CLL B cells for plasma cell differentiation and immunoglobulin production. The XII International Workshop On CLL; September 14-16, 2007; London, UK.

19. B. A. McCarthy, Tipping, M.E., Wang, X.P., Bennett, F., Li, W., Lesser, M., Paul, S., Boyle E., Moreno, C., Messmer, B., Gregersen, PK. , Rawstron A.C., Rai, K., and Chiorazzi, N. Gene Expression Profiling Can Distinguish and Predict Physiologic Clonal Expansions of Pre-leukemic (MBL) and Leukemic (B-CLL) B Cells from Normal B Cells. The XII International Workshop On CLL; September 14-16, 2007; London, UK.

20. Surya Acharya, Krishnendu Acharya and Santanu Paul. Diversity in antioxidant and anti-leukemic potential of Fenugreek genotypes grown in western Canada. XII th World Congress on Clinical Nutrition. June 17-20, 2007, Alberta, Canada.

21. Santanu Paul, Rasmi AbuHelu, Pat Mongini, Kanti Rai and Nicholas Chiorazzi.Fate Discrimination of Normal B Cells when Cross-linked with Anti-IgM Antibodies of Different Affinities and Valence; December 8-12, 2006, Orlando, Florida, USA.

22.Brian McCarthy, Santanu Paul, Xue-Ping Wang, Leslie Goodwin, Andrew Rawstron, and Nicholas Chiorazzi. Gene Expression Profiling Can Distinguish Physiologic B-CLL Clonal Expansions from Pre-leukemic and Leukemic Clones; March 16-18, 2006; Washington, DC, USA. [This work has been selected as the Winner of the Clinical Research 2006 Outstanding Junior Investigator Award]

23.Xue-Ping Wang, Santanu Paul, Brian McCarthy, Nicholas Chiorazzi, Andrew Rawstron and Leslie Goodwin. Integrity of Gene Expression Patterns from Small Samples of Distinct Tumor Types with Nugen OVATION RNA Amplification System (ORAS); An International Symposium Sponsored by the Association of Biomolecular Resource Facilities; February 11-14, 2006,Long Beach Convention Center; California, USA.

24.Mausumi Paul, Saikat Kumar Basu and Santanu Paul. Bioleaching of metal from municipal waste using a mixed culture of sulfur-oxidizing and iron-oxidizing bacteria. International Symposium on Agriculturally Important Microorganisma: Conservation, Utilization, Bioremediation and Ecological Significance. February 23-25, 2006, Calcutta University, Department of Botany, Kolkata, India.

25.Saikat Kumar Basu and Santanu Paul. Recent methodologies in bioremediation of natural environment by the use of suitable microbes. International Symposium on Agriculturally Important Microorganisma: Conservation, Utilization, Bioremediation and Ecological Significance. February 23-25, 2006, Calcutta University, Department of Botany, Kolkata, India.

26. Santanu Paul, Steven L. Allen, Kanti R. Rai, and Nicholas Chiorazzi. Expression of angiogenin in normal B lymphocytes and B-CLL cells. The American Society of Hematology 47th Annual Meeting; December 10-13; Atlanta, Georgia, USA.

27.Santanu Pal, Shyamasree Ghosh, Chhabinath Mandal, Asish Mallick & Chitra Mandal. O-acetylated sialoglycoconjugates, a novel biomarker for monitoring childhood Acute Lymphoblastic Leukemia (ALL). 6th International Symposium on Biochemical Roles of Eukaryotic Cell Surface Macromolecules. (Founded by late Prof. B.K.Bachhawat); January 16-18, 2003.

28. Chitra Mandal, Santanu Pal, Dilip Kumar Bhattacharya . Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukaemia. 20th International Carbohydrate Symposium – ICS.August 27- September 1, 2000, Hamburg, Germany

29.Chitra Mandal, Santanu Pal, Brossmeir Reinhard. Study of carbohydrate specificity of disease specific antibodies (IgM) induced in childhood Acute Lymphoblastic Leukemia (ALL) using various sialic acid analogues. 20th International Carbohydrate Symposium – ICS. August 27- September 1, 2000, Hamburg, Germany

30. Mandal Chitra, Pal Santanu, Chatterjee Mitali, Sinha Diviya and Bhattacharya K. Dilip. Differential expression of 9-O-acetylated sialoglycoconjugates (9-O-AcSGs) on lymphoblasts of childhood acute lymphoblastic leukemia (ALL) patients as evaluated by lectin and human antibodies.7th WORKSHOP & CONFERENCE ON HUMAN LEUCOCYTE DIFFERENTIATION ANTIGENS. HARROGATE ; June 20-24 ; 2000

31. Mandal Chitra, Pal Santanu, Chatterjee Mitali, Hall Andrew, Minto Lynne, and Bhattacharya K. Dilip. Diagnostic and prognostic potential of cytolytic antibodies directed against O-acetylated sialic acid (O-AcSA) in childhood acute lymphoblastic leukaemia (ALL). 7th WORKSHOP & CONFERENCE ON HUMAN LEUCOCYTE DIFFERENTIATION ANTIGENS. HARROGATE ; June 20-24 ; 2000.

32. Santanu Pal, Chitra Mandal, Dilip Kumar Bhattacharya. Diagnostic and prognostic potential of cytolytic antibodies directed against O-Acetylated sialic acid in childhood acute lymphoblastic leukemia (ALL). Biomedical Research in India : Perspective and Prospects. (Dr. J.C. Roy Birth Centenary Celebration.); Calcutta; Feb : 27-28 ; 2000.

33. Santanu Pal, Diviya Sinha , Chitra Mandal, Dilip Kumar Bhattacharya. Identification and purification of a novel antibody directed against O-Acetylated sialic acid (9-O-AcSA) in childhood acute lymphoblastic leukemia (ALL). Satellite Symposium on Tumor Immunology. Calcutta (India);Oct : 28-30 ; 1998.

34. Diviya Sinha , Santanu Pal, Chitra Mandal, Dilip Kumar Bhattacharya Mechanism of interaction of ATNH with novel biomarkers (9-O-AcSGs) on lymphoblasts of in childhood acute lymphoblastic leukemia (ALL). Satellite Symposium on Tumor Immunology. Calcutta (India);Oct : 28-30 ; 1998.

35. Chitra Mandal, , Diviya Sinha, Santanu Pal, Dilip Kumar Bhattacharya A new approach to determine tratment outcome in in childhood acute lymphoblastic leukemia (ALL). Satellite Symposium on Tumor Immunology. Calcutta (India); Oct : 28-30 ; 1998.

Collaborations

Scientist’s Name Organisation Country
Dr. Nicholas Chiorazzi Feinstein Institute for Medical Research; Manhasset, New York; 11040 USA
Dr. Yousef AlAbed Feinstein Institute for Medical Research; Manhasset, New York; 11040 USA
Dr. Surya Acharya University of Alberta; Lethbridge; T1J4B1 CANADA
Dr. Chitra Mandal Department of Cancer and Cell Biology; Indian Institute of Chemical Biology (IICB); Kolkata; 700032. INDIA
Dr.Ruma Pal Department of Botany,University of Calcutta; Kolkata; 700019. INDIA
Dr. Nirup Bikash Mandal Department of Chemistry; Indian Institute of Chemical Biology (IICB); Kolkata; 700032. INDIA
Dr. Chinmay Choudhury Department of Chemistry; Indian Institute of Chemical Biology (IICB); Kolkata; 700032. INDIA
Dr. Krsihnendu Acharya Department of Botany, Calcutta University; Kolkata; 700019 INDIA
Dr. Saurabh Das Department of Chemistry, Jadavpur University; Kolkata 700032 INDIA
Dr. Sumi Bandyopadhyay Department of Laboratory Medicine; School of Tropical Medicine; Kolkata 700073 INDIA
Dr. Mitali Chatterjee Department of Pharmacology: Institute of Post Graduate Medical Institute and Research (IPGMER); Kolkata 700020 INDIA
Dr. Surojit Chatterjee Department of Chemistry: Kalyani University INDIA